Items where Author is "Sporrer, D."
 | Up a level |
Article
Sporrer, D. and Weber, M. and Wanninger, J. and Weigert, J. and Neumeier, M. and Stoegbauer, F. and Lieberer, E. and Bala, M. and Kopp, A. and Schaeffler, A. and Buechler, C. (2009) Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 39 (8). pp. 671-679. ISSN 0014-2972, 1365-2362
Other
Sporrer, D. and Koestler, J. and Gessner, A. and Oefner, P. and Hahn, J. and Peter, K. and Kreutz, M. and Herr, W. and Holler, E. (2015) Prophylaxis with Rifaximin preserves microbiome diversity in ASCT. NATURE PUBLISHING GROUP, LONDON.
Sporrer, D. and Koestler, J. and Gessner, A. and Oefner, P. and Hahn, J. and Holler, E. (2014) THE IMPACT OF ENTEROCOCCAL FLORA ON INTESTINAL GVHD AND OVERALL SURVIVAL. NATURE PUBLISHING GROUP, LONDON.
Holler, E. and Kreutz, M. and Ferrara, J. and Schmid, K. and Peter, K. and Sporrer, D. and Ner, S. Haff and Wolff, D. and Herr, W. and Levine, J. (2014) INCREASED REG3A SERUM LEVELS CORRELATE WITH SEVERE GASTROINTESTINAL DAMAGE FROM EARLY ACUTE GI GVHD, LATE ACUTE GI GVHD AND NEUTROPENIC ENTEROCOLITIS. NATURE PUBLISHING GROUP, LONDON.
Hautmann, A. H. and Wolff, D. and Hilgendorf, I and Fehn, U. and Edinger, M. and Herr, W. and Koelbl, O. and Holler, B. and Sporrer, D. and Holler, E. and Hautmann, M. G. (2014) Total nodal irradiation in patients with severe and mostly corticosteroid-refractory chronic graft-versus-host-disease after allogeneic stem cell transplantation. KARGER, BASEL.
Kessler, E. M. and Fehn, U. and Koehler, M. and Holler, B. and Gemerodt, M. and Sporrer, D. and Holler, E. and Andreesen, R. and Hoffmann, P. and Edinger, M. and Wolff, D. (2013) Altered immune-reconstitution of B- and T-cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset. NATURE PUBLISHING GROUP, LONDON.
Sporrer, D. and Koestler, J. and Gessner, A. and Oefner, P. and Holler, E. (2013) The Influence of Rifaximin prophylaxis on intestinal microbiota, GvHD and infections in ASCT. KARGER, BASEL.
